The largest database of trusted experimental protocols

Fix perm medium a and b

Manufactured by Thermo Fisher Scientific
Sourced in United States

FIX & PERM medium A and B are laboratory reagents used for the fixation and permeabilization of cells. Medium A is a fixative solution, while Medium B is a permeabilization solution. These reagents are commonly used in preparation for downstream applications such as flow cytometry and immunocytochemistry.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using fix perm medium a and b

1

Splenic T-cell Phenotyping by Flow

Check if the same lab product or an alternative is used in the 5 most similar protocols
The splenic tissue was harvested, and single-cell suspensions were prepared for each sample containing 1*109 cells treated with cell lysis buffer (BD Pharm Lyse™, AB_2869057, USA). Then, sections were stained with or without anti-CD4 and anti-CD25 and treated with FIX & PERM medium A and B (Invitrogen, USA). Later, it was also stained with anti-FoxP3. A parallel control group was treated with isotype controls. Flow cytometry was performed using MACSQuant Analyzer (Miltenyi Biotec, Bergisch Gladbach, Germany), and data were analyzed using the Flowjo software version 10.0 (Tree Star, Ashland, OR, USA).
+ Open protocol
+ Expand
2

Treg and Th17 Cell Enumeration

Check if the same lab product or an alternative is used in the 5 most similar protocols
All antibodies listed were obtained from eBioscience (San Diego, CA, USA). A total of 5 μL labeled antibodies was added in each procedure. Because the PMA culture stimulates PBMC, it produces endocytosis of CD4 on the cell surface, which interferes with CD4 flow cytometric staining. As a result, CD3+CD8 T cells were employed to counter-select CD4+ T cells in this investigation. Stimulated and cultured mononuclear cells were collected, pre-incubated for 15 min with unlabeled isotype control Abs (IgG1 or IgG2b), and then incubated with anti-CD3-FITC, anti-CD8-PE, or anti-CD4-FITC and anti-CD25-PE. A parallel control group was treated with their isotype controls. Then, mononuclear cells were treated with 100 μL FIX & PERM medium A and B (Invitrogen). Then, anti-IL-17-APC or anti-FoxP3-APC was added to PBMCs. A parallel control group was treated with isotype controls. Both suspensions were incubated at 4 °C away from light for one night. The markers for Treg cells and Th17 cells were CD4+CD25+FoxP3+, CD4+IL17+(unstimulated with PMA), or CD3+CD8IL17+ (stimulated with PMA), respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!